Teligent, Inc. Announces First Quarter 2018 Results
May 08, 2018 08:00 ET
|
Teligent, Inc.
BUENA, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...
Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday, May 8, 2018
May 07, 2018 18:36 ET
|
Teligent, Inc.
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care...
Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results
May 07, 2018 17:50 ET
|
Teligent, Inc.
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call...
Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018
May 01, 2018 16:30 ET
|
Teligent, Inc.
BUENA, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care...
Teligent, Inc. Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023
April 27, 2018 09:25 ET
|
Teligent, Inc.
BUENA, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT) (“Teligent”) announced today that it has entered into separate, privately negotiated exchange agreements with certain...
Teligent, Inc. to Hold Conference Call for First Quarter 2018 Results
April 26, 2018 14:15 ET
|
Teligent, Inc.
BUENA, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%
April 17, 2018 16:35 ET
|
Teligent, Inc.
BUENA, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%
April 06, 2018 10:32 ET
|
Teligent, Inc.
BUENA, N.J., April 06, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%
March 21, 2018 08:30 ET
|
Teligent, Inc.
BUENA, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces Fourth Quarter and Year End 2017 Results
March 15, 2018 16:10 ET
|
Teligent, Inc.
BUENA, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...